Integra LifeSciences Holdings Corp (IART) bonds
Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Integra LifeSciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Integra LifeSciences's 10-Q for the period ended Sep 30, 2026
| Issue | Coupon |
|---|---|
| 2025 Notes Convertible at $74 a share | 0.50% |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Revolving Credit Facility | $1.30B |
| Senior Credit Facility | $2.10B |
| Standby Letters of Credit | $60.00M |
| Swingline Loan | $60.00M |
| Swingline Loans | $60.00M |
| Term Loan Facility | $775.00M |
See a number that looks wrong?